Rheumatology

Complement system

Questions discussed in this category

Which patients may benefit from eculizumab in refractory APS?

2 Answers available

Papers discussed in this category

Clinical immunology (Orlando, Fla.), 2019-09

Treatment of antiphospholipid syndrome beyond anticoagulation.

Seminars in arthritis and rheumatism, 2019-08

Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.

Related Topics in Rheumatology